NSE › Healthcare

Lincoln Pharmaceuticals Limited (LINCOLN)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹580.75+0.13%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

₹187 cr

Revenue YoY

+11.4%

Net profit

₹12 cr

Profit YoY

+0.5%

EPS

₹10.46

EPS estimate

₹9.51

Net margin

6.2%

EPS came in at 10.46 against a street estimate of 9.51 — a beat of 10.0%.

Key statistics

Market cap

₹1,154 cr

P/E

13.1

Forward P/E

0.0

P/B

1.53

Book value

₹378.34

EPS (TTM)

₹43.86

Dividend yield

0.31%

52-week high

₹770.00

52-week low

₹440.00

50-day MA

₹621.53

200-day MA

₹571.64

Beta

0.36

Shareholding

Promoters

56.11%

Institutions

1.06%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Lincoln Pharmaceuticals Limited — free to start.

Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Cipla Limited Zydus Lifesciences Limited Lupin Limited Max Healthcare Institute Limited Mankind Pharma Ltd Laurus Labs Limited Lenskart Solutions Ltd Dr. Reddy's Laboratories Limited

Data updated 2026-08-05.